Dren Bio
Jeff Macfarland joined as our SVP of Finance in May 2021. Mr. Macfarland most recently served as VP of Finance for Allakos. During his time at Allakos, he helped raise over $900 million dollars in private and public company financings, including their initial public offering in July 2018. Prior to joining Allakos, Mr. Macfarland provided finance and accounting consulting services to early stage, pre-IPO life science companies, including work on multiple S-1 filings. Mr. Macfarland began his career at Deloitte, one of the Big Four accounting firms, after obtaining his Bachelor of Science degree in accounting from the State University of New York at Albany.
Dren Bio
1 followers
Dren Bio is a San Carlos, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.